|
1
|
Debela DT, Muzazu SG, Heraro KD, Ndalama
MT, Mesele BW, Haile DC, Kitui SK and Manyazewal T: New approaches
and procedures for cancer treatment: Current perspectives. SAGE
Open Med. 9(20503121211034366)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lankadasari MB, Mukhopadhyay P, Mohammed S
and Harikumar KB: TAMing pancreatic cancer: Combat with a double
edged sword. Mol Cancer. 18(48)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Balkwill FR, Capasso M and Hagemann T: The
tumor microenvironment at a glance. J Cell Sci. 125:5591–5596.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Anderson NM and Simon MC: The tumor
microenvironment. Curr Biol. 30:R921–R925. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhong H, Zhou S, Yin S, Qiu Y, Liu B and
Yu H: Tumor microenvironment as niche constructed by cancer stem
cells: Breaking the ecosystem to combat cancer. J Adv Res.
71:279–296. 2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cukierman E and Bassi DE: The mesenchymal
tumor microenvironment. Cell Adhesion Migration. 6:285–296.
2014.
|
|
7
|
Mbah NE and Lyssiotis CA: Metabolic
regulation of ferroptosis in the tumor microenvironment. J Biol
Chem. 298(101617)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Colegio OR, Chu NQ, Szabo AL, Chu T,
Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC,
Phillips GM, et al: Functional polarization of tumour-associated
macrophages by tumour-derived lactic acid. Nature. 513:559–563.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hirschhaeuser F, Sattler UGA and
Mueller-Klieser W: Lactate: A metabolic key player in cancer.
Cancer Res. 71:6921–6925. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang ZH, Peng WB, Zhang P, Yang XP and
Zhou Q: Lactate in the tumour microenvironment: From immune
modulation to therapy. EBioMedicine. 73(103627)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Le A, Cooper CR, Gouw AM, Dinavahi R,
Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL and Dang
CV: Inhibition of lactate dehydrogenase A induces oxidative stress
and inhibits tumor progression. Proc Natl Acad Sci USA.
107:2037–2042. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Brand A, Singer K, Koehl GE, Kolitzus M,
Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, et
al: LDHA-associated lactic acid production blunts tumor
immunosurveillance by T and NK cells. Cell Metab. 24:657–671.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pavlides S, Whitaker-Menezes D,
Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro
MC, Wang C, Fortina P, Addya S, et al: The reverse Warburg effect:
Aerobic glycolysis in cancer associated fibroblasts and the tumor
stroma. Cell Cycle. 8:3984–4001. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Martinez-Outschoorn UE, Trimmer C, Lin Z,
Whitaker-Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S,
Martinez-Cantarin MP, Capozza F, et al: Autophagy in cancer
associated fibroblasts promotes tumor cell survival: Role of
hypoxia, HIF1 induction and NFκB activation in the tumor stromal
microenvironment. Cell Cycle. 9:3515–3533. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ganguly D, Chandra R, Karalis J, Teke M,
Aguilera T, Maddipati R, Wachsmann MB, Ghersi D, Siravegna G, Zeh
HJ III, et al: Cancer-associated fibroblasts: Versatile players in
the tumor microenvironment. Cancers (Basel).
12(2652)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fantin VR, St-Pierre J and Leder P:
Attenuation of LDH-A expression uncovers a link between glycolysis,
mitochondrial physiology, and tumor maintenance. Cancer Cell.
9:425–434. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li X, Yang Y, Zhang B, Lin X, Fu X, An Y,
Zou Y, Wang JX, Wang Z and Yu T: Lactate metabolism in human health
and disease. Signal Transduct Target Ther. 7(305)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pereira-Nunes A, Afonso J, Granja S and
Baltazar F: Lactate and lactate transporters as key players in the
maintenance of the Warburg effect. Adv Exp Med Biol. 1219:51–57.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kumagai S, Koyama S, Itahashi K,
Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono
H, et al: Lactic acid promotes PD-1 expression in regulatory T
cells in highly glycolytic tumor microenvironments. Cancer Cell.
40:201–218.e9. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tasdogan A, Faubert B, Ramesh V,
Ubellacker JM, Shen B, Solmonson A, Murphy MM, Gu Z, Gu W, Martin
M, et al: Metabolic heterogeneity confers differences in melanoma
metastatic potential. Nature. 577:115–120. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Corbet C and Feron O: Tumour acidosis:
From the passenger to the driver's seat. Nat Rev Cancer.
17:577–593. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bhagat TD, Von Ahrens D, Dawlaty M, Zou Y,
Baddour J, Achreja A, Zhao H, Yang L, Patel B, Kwak C, et al:
Lactate-mediated epigenetic reprogramming regulates formation of
human pancreatic cancer-associated fibroblasts. Elife.
8(e50663)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ippolito L, Duatti A, Iozzo M, Comito G,
Pardella E, Lorito N, Bacci M, Pranzini E, Santi A, Sandrini G, et
al: Lactate supports cell-autonomous ECM production to sustain
metastatic behavior in prostate cancer. EMBO Rep. 25:3506–3531.
2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen S, Xu Y, Zhuo W and Zhang L: The
emerging role of lactate in tumor microenvironment and its clinical
relevance. Cancer Lett. 590(216837)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Certo M, Tsai CH, Pucino V, Ho PC and
Mauro C: Lactate modulation of immune responses in inflammatory
versus tumour microenvironments. Nat Rev Immunol. 21:151–161.
2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hui S, Ghergurovich JM, Morscher RJ, Jang
C, Teng X, Lu W, Esparza LA, Reya T, Le Zhan Yanxiang Guo J, et al:
Glucose feeds the TCA cycle via circulating lactate. Nature.
551:115–118. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Roland CL, Arumugam T, Deng D, Liu SH,
Philip B, Gomez S, Burns WR, Ramachandran V, Wang H,
Cruz-Monserrate Z, et al: Cell surface lactate receptor GPR81 is
crucial for cancer cell survival. Cancer Res. 74:5301–5310.
2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Feng X, Li D, Wang P, Li X and Li G:
Lactylation in cancer: Unlocking the key to drug resistance and
therapeutic breakthroughs. Oncol Res. 33:3327–3346. 2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L,
Xu Y, He J, Lan J, Ou Q, et al: Tumor-derived lactate promotes
resistance to bevacizumab treatment by facilitating autophagy
enhancer protein RUBCNL expression through histone H3 lysine 18
lactylation (H3K18la) in colorectal cancer. Autophagy. 20:114–130.
2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hoxhaj G and Manning BD: The PI3K-AKT
network at the interface of oncogenic signalling and cancer
metabolism. Nat Rev Cancer. 20:74–88. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Turner NC, Oliveira M, Howell SJ, Dalenc
F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl
S, et al: Capivasertib in hormone receptor-positive advanced breast
cancer. N Engl J Med. 388:2058–2070. 2023.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Barnes EME, Xu Y, Benito A, Herendi L,
Siskos AP, Aboagye EO, Nijhuis A and Keun HC: Lactic acidosis
induces resistance to the pan-Akt inhibitor uprosertib in colon
cancer cells. Br J Cancer. 122:1298–1308. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Duan W, Liu W, Xia S, Zhou Y, Tang M, Xu
M, Lin M, Li X and Wang Q: Warburg effect enhanced by AKR1B10
promotes acquired resistance to pemetrexed in lung cancer-derived
brain metastasis. J Transl Med. 21(547)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kennedy KM, Scarbrough PM, Ribeiro A,
Richardson R, Yuan H, Sonveaux P, Landon CD, Chi JT, Pizzo S,
Schroeder T and Dewhirst MW: Catabolism of exogenous lactate
reveals it as a legitimate metabolic substrate in breast cancer.
PLoS One. 8(e75154)2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sun K, Tang S, Hou Y, Xi L, Chen Y, Yin J,
Peng M, Zhao M, Cui X and Liu M: Oxidized ATM-mediated glycolysis
enhancement in breast cancer-associated fibroblasts contributes to
tumor invasion through lactate as metabolic coupling. EBioMedicine.
41:370–383. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Linares JF, Cid-Diaz T, Duran A, Osrodek
M, Martinez-Ordoñez A, Reina-Campos M, Kuo HH, Elemento O, Martin
ML, Cordes T, et al: The lactate-NAD+ axis activates
cancer-associated fibroblasts by downregulating p62. Cell Rep.
39(110792)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wang N, Liu W, Zheng Y, Wang S, Yang B, Li
M, Song J, Zhang F, Zhang X, Wang Q and Wang Z: CXCL1 derived from
tumor-associated macrophages promotes breast cancer metastasis via
activating NF-κB/SOX4 signaling. Cell Death Dis.
9(880)2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhao Y, Wang D, Xu T, Liu P, Cao Y, Wang
Y, Yang X, Xu X, Wang X and Niu H: Bladder cancer cells re-educate
TAMs through lactate shuttling in the microfluidic cancer
microenvironment. Oncotarget. 6:39196–39210. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu N, Luo J, Kuang D, Xu S, Duan Y, Xia
Y, Wei Z, Xie X, Yin B, Chen F, et al: Lactate inhibits ATP6V0d2
expression in tumor-associated macrophages to promote
HIF-2α-mediated tumor progression. J Clin Invest. 129:631–646.
2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kes MMG, Van den Bossche J, Griffioen AW
and Huijbers EJM: Oncometabolites lactate and succinate drive
pro-angiogenic macrophage response in tumors. Biochim Biophys Acta
Rev Cancer. 1874(188427)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mendler AN, Hu B, Prinz PU, Kreutz M,
Gottfried E and Noessner E: Tumor lactic acidosis suppresses CTL
function by inhibition of p38 and JNK/c-Jun activation. Int J
Cancer. 131:633–640. 2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xie D, Zhu S and Bai L: Lactic acid in
tumor microenvironments causes dysfunction of NKT cells by
interfering with mTOR signaling. Sci China Life Sci. 59:1290–1296.
2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Apostolova P and Pearce EL: Lactic acid
and lactate: Revisiting the physiological roles in the tumor
microenvironment. Trends Immunol. 43:969–977. 2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Decking SM, Bruss C, Babl N, Bittner S,
Klobuch S, Thomas S, Feuerer M, Hoffmann P, Dettmer K, Oefner PJ,
et al: LDHB overexpression can partially overcome T cell inhibition
by lactic acid. Int J Mol Sci. 23(5970)2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Caronni N, Simoncello F, Stafetta F,
Guarnaccia C, Ruiz-Moreno JS, Opitz B, Galli T, Proux-Gillardeaux V
and Benvenuti F: Downregulation of membrane trafficking proteins
and lactate conditioning determine loss of dendritic cell function
in lung cancer. Cancer Res. 78:1685–1699. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Gottfried E, Kunz-Schughart LA, Ebner S,
Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A and Kreutz M:
Tumor-derived lactic acid modulates dendritic cell activation and
antigen expression. Blood. 107:2013–2021. 2006.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Raychaudhuri D, Bhattacharya R, Sinha BP,
Liu CSC, Ghosh AR, Rahaman O, Bandopadhyay P, Sarif J, D'Rozario R,
Paul S, et al: Lactate induces Pro-tumor reprogramming in
intratumoral plasmacytoid dendritic cells. Front Immunol.
10(1878)2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Watson MJ, Vignali PDA, Mullett SJ,
Overacre-Delgoffe AE, Peralta RM, Grebinoski S, Menk AV,
Rittenhouse NL, DePeaux K, Whetstone RD, et al: Metabolic support
of tumour-infiltrating regulatory T cells by lactic acid. Nature.
591:645–651. 2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zhou J, Gu J, Qian Q, Zhang Y, Huang T, Li
X, Liu Z, Shao Q, Liang Y, Qiao L, et al: Lactate supports Treg
function and immune balance via MGAT1 effects on N-glycosylation in
the mitochondria. J Clin Invest. 134(e175897)2024.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Angelin A, Gil-de-Gomez L, Dahiya S, Jiao
J, Guo L, Levine MH, Wang Z, Quinn WJ III, Kopinski PK, Wang L, et
al: Foxp3 reprograms T cell metabolism to function in low-glucose,
high-lactate environments. Cell Metab. 25:1282–1293.e7.
2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chattopadhyay A and Ferreira LMR: Why
regulatory T cells love lactic acid. Mol Ther Methods Clin Dev.
33(101647)2025.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gu XY, Yang JL, Lai R, Zhou ZJ, Tang D, Hu
L and Zhao LJ: Impact of lactate on immune cell function in the
tumor microenvironment: Mechanisms and therapeutic perspectives.
Front Immunol. 16(1563303)2025.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X,
Shao Q, Zhou B, Zhou H, Wei S, et al: Tumor metabolite lactate
promotes tumorigenesis by modulating MOESIN lactylation and
enhancing TGF-beta signaling in regulatory T cells. Cell Rep.
40(111122)2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Tuomela K and Levings MK: Acidity promotes
the differentiation of immunosuppressive regulatory T cells. Eur J
Immunol. 53(e2350511)2023.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Rao D, Stunnenberg JA, Lacroix R,
Dimitriadis P, Kaplon J, Verburg F, van van Royen PT, Hoefsmit EP,
Renner K, Blank CU and Peeper DS: Acidity-mediated induction of
FoxP3+ regulatory T cells. Eur J Immunol.
53(e2250258)2023.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wagner K, Sami MA, Norton C, McCoy J and
Hassan U: Profiling single-cell level phagocytic activity
distribution with blood lactate levels. RSC Adv. 11:21315–21322.
2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Fei M, Zhang H, Meng F, An G, Tang J, Tong
J, Xiong L, Liu Q and Li C: Enhanced lactate accumulation
upregulates PD-L1 expression to delay neutrophil apoptosis in
sepsis. View: 5, 2023 doi: 10.1002/VIW.20230053.
|
|
60
|
Husain Z, Huang Y, Seth P and Sukhatme VP:
Tumor-derived lactate modifies antitumor immune response: Effect on
myeloid-derived suppressor cells and NK cells. J Immunol.
191:1486–1495. 2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Li W, Tanikawa T, Kryczek I, Xia H, Li G,
Wu K, Wei S, Zhao L, Vatan L, Wen B, et al: Aerobic glycolysis
controls myeloid-derived suppressor cells and tumor immunity via a
specific CEBPB isoform in triple-negative breast cancer. Cell
Metab. 28:87–103.e6. 2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zhao JL, Ye YC, Gao CC, Wang L, Ren KX,
Jiang R, Hu SJ, Liang SQ, Bai J, Liang JL, et al: Notch-mediated
lactate metabolism regulates MDSC development through the
Hes1/MCT2/c-Jun axis. Cell Rep. 38(110451)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Yang X, Lu Y, Hang J, Zhang J, Zhang T,
Huo Y, Liu J, Lai S, Luo D, Wang L, et al: Lactate-modulated
immunosuppression of myeloid-derived suppressor cells contributes
to the radioresistance of pancreatic cancer. Cancer Immunol Res.
8:1440–1451. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Martinez-Outschoorn UE, Peiris-Pages M,
Pestell RG, Sotgia F and Lisanti MP: Cancer metabolism: A
therapeutic perspective. Nat Rev Clin Oncol. 14(113)2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Pelicano H, Martin DS, Xu RH and Huang P:
Glycolysis inhibition for anticancer treatment. Oncogene.
25:4633–4646. 2006.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Luengo A, Gui DY and Vander Heiden MG:
Targeting metabolism for cancer therapy. Cell Chem Biol.
24:1161–1180. 2017.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Ganapathy-Kanniappan S and Geschwind JF:
Tumor glycolysis as a target for cancer therapy: Progress and
prospects. Mol Cancer. 12(152)2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lee SY, Park JH, Ko SH, Shim JS, Kim DD
and Cho HJ: Mussel-inspired hyaluronic acid derivative
nanostructures for improved tumor targeting and penetration. ACS
Appl Mater Interfaces. 9:22308–22320. 2017.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Dai Z, Wang Q, Tang J, Qu R, Wu M, Li H,
Yang Y, Zhen X and Yu C: A Sub-6 nm
MnFe2O4-dichloroacetic acid nanocomposite
modulates tumor metabolism and catabolism for reversing tumor
immunosuppressive microenvironment and boosting immunotherapy.
Biomaterials. 284(121533)2022.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Huang J, Zhuang C, Chen J, Chen X, Li X,
Zhang T, Wang B, Feng Q, Zheng X, Gong M, et al: Targeted
drug/Gene/Photodynamic therapy via a stimuli-responsive
dendritic-polymer-based nanococktail for treatment of
EGFR-TKI-resistant non-small-cell lung cancer. Adv Mater.
34(e2201516)2022.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Tian Z, Yang K, Yao T, Li X, Ma Y, Qu C,
Qu X, Xu Y, Guo Y and Qu Y: Catalytically selective chemotherapy
from tumor-metabolic generated lactic acid. Small.
15(e1903746)2019.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Tseng SJ, Kempson IM, Huang KY, Li HJ, Fa
YC, Ho YC, Liao ZX and Yang PC: Targeting tumor microenvironment by
bioreduction-activated nanoparticles for light-triggered
virotherapy. ACS Nano. 12:9894–9902. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Jiang D, Ni D, Rosenkrans ZT, Huang P, Yan
X and Cai W: Nanozyme: New horizons for responsive biomedical
applications. Chem Soc Rev. 48:3683–3704. 2019.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Gao M, Wang Z, Zheng H, Wang L, Xu S, Liu
X, Li W, Pan Y, Wang W, Cai X, et al: Two-dimensional tin selenide
(SnSe) nanosheets capable of mimicking key dehydrogenases in
cellular metabolism. Angew Chem Int Ed Engl. 59:3618–3623.
2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Dos Reis SA, da Conceicao LL, Siqueira NP,
Rosa DD, da Silva LL and Peluzio MD: Review of the mechanisms of
probiotic actions in the prevention of colorectal cancer. Nutr Res.
37:1–19. 2017.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Sheng B, Xu J, Zhang Y, Jiang T, Deng S,
Kong J, Gao C, Ma C and Xu P: Utilization of D-Lactate as an Energy
Source Supports the Growth of Gluconobacter oxydans. Appl Environ
Microbiol. 81:4098–4110. 2015.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Wang JW, Chen QW, Luo GF, Han ZY, Song WF,
Yang J, Chen WH and Zhang XZ: A Self-driven bioreactor based on
bacterium-metal-organic framework biohybrids for boosting
chemotherapy via cyclic lactate catabolism. ACS Nano.
15:17870–17884. 2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Vacca M, Celano G, Calabrese FM,
Portincasa P, Gobbetti M and De Angelis M: The controversial role
of human gut lachnospiraceae. Microorganisms. 8(573)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Fernandez-Sanjurjo M, Fernández J,
Tomás-Zapico C, Fernández-García B, Villar CJ, Lombó F and
Iglesias-Gutiérrez E: Is physical performance (in mice) increased
by Veillonella atypica or decreased by Lactobacillus
bulgaricus? J Sport Health Sci. 9:197–200. 2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Ullah MS, Davies AJ and Halestrap AP: The
plasma membrane lactate transporter MCT4, but not MCT1, is
up-regulated by hypoxia through a HIF-1α-dependent mechanism. J
Biol Chem. 281:9030–9037. 2006.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Zhao LP, Zheng RR, Kong RJ, Huang CY, Rao
XN, Yang N, Chen AL, Yu XY, Cheng H and Li SY: Self-delivery
ternary bioregulators for photodynamic amplified immunotherapy by
tumor microenvironment reprogramming. ACS Nano. 16:1182–1197.
2022.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Li K, Lin C, He Y, Lu L, Xu K, Tao B, Xia
Z, Zeng R, Mao Y, Luo Z and Cai K: Engineering of
Cascade-responsive nanoplatform to inhibit lactate efflux for
enhanced tumor chemo-immunotherapy. ACS Nano. 14:14164–14180.
2020.PubMed/NCBI View Article : Google Scholar
|
